Capsid inhibitors for the treatment of HIV

The present disclosure relates to compounds of Formula (Ia) and (Ib) or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.

Saved in:

Bibliographic Details
Main Authors	GORMAN, Eric M, STEFANIDIS, Dimitrios, CHIU, Anna, LEVINE, Dana, RHEE, Martin Sunkwang, TSE, Winston C, BAUER, Laura Elizabeth, ROWE, Charles William, YANT, Stephen R, SELLERS, Scott P, MULATO, Andrew Stephen
Format	Patent
Language	English
Published	28.01.2021
Subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online Access	Get full text

Cover

Loading…

More Information
Summary:	The present disclosure relates to compounds of Formula (Ia) and (Ib) or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.
Bibliography:	Application Number: AU20190307500